5-172670261-G-T
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_001142651.3(NEURL1B):c.508G>T(p.Val170Leu) variant causes a missense change. The variant allele was found at a frequency of 0.0000137 in 1,238,812 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001142651.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NEURL1B | NM_001142651.3 | c.508G>T | p.Val170Leu | missense_variant | Exon 2 of 5 | ENST00000369800.6 | NP_001136123.1 | |
NEURL1B | NM_001308178.2 | c.508G>T | p.Val170Leu | missense_variant | Exon 2 of 4 | NP_001295107.1 | ||
NEURL1B | NM_001308177.2 | c.32-13158G>T | intron_variant | Intron 1 of 3 | NP_001295106.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NEURL1B | ENST00000369800.6 | c.508G>T | p.Val170Leu | missense_variant | Exon 2 of 5 | 1 | NM_001142651.3 | ENSP00000358815.5 | ||
NEURL1B | ENST00000520919.5 | c.508G>T | p.Val170Leu | missense_variant | Exon 2 of 4 | 1 | ENSP00000429797.1 | |||
NEURL1B | ENST00000522853.5 | c.32-13158G>T | intron_variant | Intron 1 of 3 | 1 | ENSP00000430001.1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome AF: 0.0000137 AC: 17AN: 1238812Hom.: 0 Cov.: 31 AF XY: 0.0000150 AC XY: 9AN XY: 598782
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.508G>T (p.V170L) alteration is located in exon 2 (coding exon 2) of the NEURL1B gene. This alteration results from a G to T substitution at nucleotide position 508, causing the valine (V) at amino acid position 170 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at